Complement-Based Drug Development Summit leaderboard
  • Wednesday, October 7, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 878

Pilgrim Introduces OOS Management Software to Support Pharmaceutical Manufacturing

Oct 4, 2017
Pilgrim Quality Solutions announced the validated release of SmartSolve Out Of Specification (OOS) Management. Pilgrim’s out-of-specification software drives consistent OOS…
Read More...

MHLW approves GSK’s Benlysta in Japan for systemic lupus erythematosus

Oct 1, 2017
GSK announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic lupus erythematosus…
Read More...

Werum IT Solutions launches standalone version of its PAS-X KPI software

Sep 29, 2017
Werum IT Solutions has released a standalone version of its PAS-X KPI software product. PAS-X KPI is the only KPI/OEE tool dedicated solely to the pharmaceutical and…
Read More...

Tubilux Selects TraceLink to Achieve EU FMD Compliance

Sep 29, 2017
TraceLink announced that Tubilux has selected TraceLink's serialization solutions to help its 30+ European pharmaceutical manufacturing customers comply with the rapidly approaching…
Read More...

NewLink Genetics to evaluate IO-Based Combination Therapies in Pancreatic Cancer

Sep 28, 2017
NewLink Genetics announced that it has entered into a clinical collaboration agreement with AstraZeneca to evaluate the combination of indoximod, NewLink Genetics’ small molecule IDO…
Read More...

AstraZeneca announces positive top-line results of Phase III, PINNACLE 4 trial

Sep 28, 2017
AstraZeneca has announced positive top-line results of the Phase III, PINNACLE 4 trial in which Bevespi Aerosphere (glycopyrronium and formoterol fumarate 14.4/9.6 µg) demonstrated a…
Read More...

Genelux Initiates Phase 2 Clinical Trial of GL-ONC1 in Recurrent Ovarian Cancer

Sep 28, 2017
Genelux Corporation, a privately-held biopharmaceutical company focused on the development of its proprietary oncolytic immunotherapy platform, announced that it has treated the first…
Read More...

EC approves Symtuza for the Treatment of HIV-1 in Adults and Adolescents in Europe

Sep 27, 2017
Janssen-Cilag International NV (Janssen) announced that the European Commission has approved the use of Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide ), a once-daily…
Read More...

Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin

Sep 27, 2017
Mallinckrodt announced it closed the acquisition of InfaCare Pharmaceutical Corporation, a privately held specialty pharmaceutical company focused on development and commercialization…
Read More...

Medherant Signs Agreement with Leading Japanese Transdermal Patch Company

Sep 27, 2017
Medherant has signed an agreement with a Japanese transdermal patch company to evaluate the potential of its TEPI Patch technology to deliver a drug provided by the company.…
Read More...
Previous 1 … 876 877 878 879 880 … 956 Next
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Microbiome Movement USA Summit 2026
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
10th IPF Summit
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
17th World ADC London
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
17th World ADC San Diego
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Sanofi, Regeneron Expand Antibody Collaboration With $8B Deal
  • Abogen, Novartis Sign $7.2B RNA Therapeutics Deal
  • CAS, Novartis Partner on AI-Ready Reaction Data for Drug Discovery
  • SK pharmteco Invests $200M to Expand U.S. Drug Manufacturing
  • AstraZeneca Invests $2B in Summit Therapeutics for Cancer Research

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Direct RNA Binding Emerges as a Powerful Approach for…

AI, Structure Prediction and Advanced Computational Tools…

New Preclinical Data and Translational Advances Set to Take…

FDA, Health Canada & Leading Biopharma Organizations…

Industry Leaders Convene in Boston as Registration Remains…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.